human-papillomavirus-hpv

Documents about human-papillomavirus-hpv

• Effect of Papilozumib Oral on Vaginal and Intestinal Microbiota in HPV-Positive Women#888935ClinicalTrials.gov
• The population impact of human papillomavirus vaccination on cancer and pre-cancer outcomes: An umbrella review of meta-analyses#642292Europe PMC
• Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions#911623ClinicalTrials.gov
• Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta#883745ClinicalTrials.gov
• Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment#981946ClinicalTrials.gov
• Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma#845387ClinicalTrials.gov
• Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India#174959ClinicalTrials.gov
• An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls#459964ClinicalTrials.gov
• REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)#869872ClinicalTrials.gov
• County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana#854753ClinicalTrials.gov
• Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology#889179ClinicalTrials.gov
• Awareness of the link between HPV and cancer according to cancer type and gender in the US from 2014-2020#5167Europe PMC
• Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults#141075ClinicalTrials.gov
• Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults#195373ClinicalTrials.gov
• The Feminization of HPV: Reversing Gender Biases in US Human Papillomavirus Vaccine Policy#384214CiNii
• Infectious Risk of Vaginal Ultrasound Examination: Evaluation and Modeling From Human Papillomavirus (HPV)#841653ClinicalTrials.gov
• HPV Vaccine Communication ECHO for Primary Care Clinics#844361ClinicalTrials.gov
• CLEAR-HPV: Interpretable concept discovery for human-papillomavirus-associated morphology in whole-slide histology.#975681NCBI PubMed Central
• Human Papillomavirus vaccine knowledge and recommendation practice among primary care providers, Almaty, Kazakhstan - 2023#5151Europe PMC
• The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?#474066Spiral
• A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects with HPV Positive HNSCC.#230492ClinicalTrials.gov
• HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV#249664ClinicalTrials.gov
• Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18#238181ClinicalTrials.gov
• Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.#283110ClinicalTrials.gov
• Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial#837050ClinicalTrials.gov
• Informational Video Gaming in the Waiting Room#369771BYU ScholarsArchive
• Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma#847958ClinicalTrials.gov
• A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years#18706ClinicalTrials.gov
• HPV vaccine awareness, uptake, intention, and influencing factors among medical students in Anhui, China: A cross-sectional study#676387Europe PMC
• Comparing Strategies for Implementing Primary HPV Screening#885238ClinicalTrials.gov
• Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma#894157ClinicalTrials.gov
• Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study#127663ClinicalTrials.gov
• Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell Carcinomas#357326HAL (France)
• Perceptions of Cervical Cancer Among Asian Americans#879574ClinicalTrials.gov
• Analysis of Human Papillomavirus Capsid Proteins: Insights into Capsid Assembly#982868DigitalCommons@University of Nebraska
• Influence of U-relax on Vaginal Health Promotion and HPV DNA Test Change From Positive to Negative#914888ClinicalTrials.gov
• Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV#398196ClinicalTrials.gov
• Monitoring the safety of the adjuvanted human papillomavirus vaccine HPV-16/18-AS04 in association with pregnancy and potential immune-related diseases in China: A retrospective observational cohort study#478548Europe PMC
• Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review#4667Europe PMC
• Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women#261340ClinicalTrials.gov
• Development and Psychometric Testing of HPV Knowledge Scale#869724ClinicalTrials.gov
• Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation#842870ClinicalTrials.gov
• KAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali)#856171ClinicalTrials.gov
• Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial#868210ClinicalTrials.gov
• Prognostic Value of Human Papillomavirus (HPV) Detection in Cervical Intra-epithelial Neoplasia (CIN) Recurrence After Conization#982424ClinicalTrials.gov
• Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females#67673ClinicalTrials.gov
• The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female#810308ClinicalTrials.gov
• Long-term Immune Persistence of a Bivalent HPV Vaccine in Females From Study 311-HPV-1004#907072ClinicalTrials.gov
• AMG 319 in HPV Positive and Negative HNSCC#880348ClinicalTrials.gov
• Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi#201600ClinicalTrials.gov